Geneimmune Biotechnology Corp

Germantown, MD

UEI
TKVTR8LCJB33
CAGE
64SK4
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Asian-Pacific American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
20501 Seneca Meadows Pkwy #300f, Germantown, MD 20876, USA
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $0
FY2023 -$981

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Geneimmune Biotechnology Corp. is a biotechnology company based in Rockville, MD that specializes in a wide range of services including DNA cloning, gene mutagenesis, plasmid production, gene synthesis, protein production, and polyclonal antibody production. Through federal contract awards from the Department of Health and Human Services' National Institutes of Health, Geneimmune Biotechnology Corp. has provided various research and development services related to genetics, immunology, virology, and infectious diseases.

Specifically, Geneimmune Biotechnology Corp.'s federal contract awards have been for services such as site-directed mutagenesis, gene synthesis, plasmid preparation, DNA preparation, and subcloning for research on COVID-19 and other infectious diseases. These contracts have been prime contract awards from the National Institute of Allergy and Infectious Diseases, with no set-aside designations. Contract completion dates range from 2019 to 2023, and potential contract values range from $12,223 to $151,620. In summary, Geneimmune Biotechnology Corp. leverages its biotechnology capabilities to support federal infectious disease and immunology research through flexible research and development services provided via prime federal contracts.

Quick answers

Is Geneimmune Biotechnology Corp registered in SAM.gov?

Yes. Geneimmune Biotechnology Corp's SAM.gov registration is active through June 12, 2027.

What is Geneimmune Biotechnology Corp's most recent federal award?

Geneimmune Biotechnology Corp's most recent federal contract award is DNA prep 36542021 (75N93021P01388), from National Institute of Allergy and Infectious Diseases (NIH), on September 10, 2021.

On GovTribe

See Geneimmune Biotechnology Corp's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors